Autosomal dominant cerebellar ataxia type I
MONDO:0019792Autosomal dominant cerebellar ataxia (ADCA) type I is a group of spinocerebellar ataxias (SCAs) characterized by ataxia with other neurological signs, including oculomotor disturbances, cognitive deficits, pyramidal and extrapyramidal dysfunction, bulbar, spinal and peripheral nervous system involvement.
Also known as: ADCA1, ADCAI, autosomal dominant cerebellar ataxia type 1, cerebellar plus syndrome
35 clinical trials for this condition and its sub-types, 0 tagged with Autosomal dominant cerebellar ataxia type I itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Autosomal dominant cerebellar ataxia type I
-
Machado-Joseph disease 11 trials
4 sub-types
- Machado-Joseph disease type 3 2 trials
- Machado-Joseph disease type 1 0 trials
- Machado-Joseph disease type 2 0 trials
- Machado-Joseph disease type 4 0 trials
-
Spinocerebellar ataxia type 1 10 trials
-
Spinocerebellar ataxia type 2 10 trials
1 sub-type
-
Spinocerebellar ataxia type 8 4 trials
-
Spinocerebellar ataxia type 27 2 trials
-
Spinocerebellar ataxia type 23 1 trial
-
Spinocerebellar ataxia type 29 1 trial
-
Spinocerebellar ataxia 46 0 trials
-
Spinocerebellar ataxia type 12 0 trials
-
Spinocerebellar ataxia type 13 0 trials
-
Spinocerebellar ataxia type 14 0 trials
-
Spinocerebellar ataxia type 15/16 0 trials
-
Spinocerebellar ataxia type 17 0 trials
-
Spinocerebellar ataxia type 18 0 trials
-
Spinocerebellar ataxia type 19/22 0 trials
-
Spinocerebellar ataxia type 20 0 trials
-
Spinocerebellar ataxia type 21 0 trials
-
Spinocerebellar ataxia type 25 0 trials
-
Spinocerebellar ataxia type 28 0 trials
-
Spinocerebellar ataxia type 32 0 trials
-
Spinocerebellar ataxia type 34 0 trials
-
Spinocerebellar ataxia type 35 0 trials
-
Spinocerebellar ataxia type 36 0 trials
-
Spinocerebellar ataxia type 37 0 trials
-
Spinocerebellar ataxia type 4 0 trials
-
Spinocerebellar ataxia type 40 0 trials
We haven't found any trials for this condition yet. Follow it to get notified when new trials appear.